Assembly Biosciences (FRA:V7B) Research & Development : €54.66 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Assembly Biosciences Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Assembly Biosciences's Research & Development for the three months ended in Mar. 2025 was €13.74 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was €54.66 Mil.

Assembly Biosciences Research & Development Historical Data

The historical data trend for Assembly Biosciences's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Assembly Biosciences Research & Development Chart

Assembly Biosciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Research & Development

Get a 7-Day Free Trial

87.81

60.64

66.06

44.84

53.42

Assembly Biosciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Research & Development	Get a 7-Day Free Trial															10.93	15.11	12.18	13.64	13.74

Assembly Biosciences Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €54.66 Mil.

Assembly Biosciences (FRA:V7B) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Assembly Biosciences Research & Development Related Terms

Thank you for viewing the detailed overview of Assembly Biosciences's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Assembly Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Assembly Biosciences Inc (FRA:V7B) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ASMB:USA

Address

Two Tower Place, 7th Floor, South San Francisco, CA, USA, 94080

Website

https://www.assemblybio.com

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Assembly Biosciences Headlines

No Headlines